Enanta Pharmaceuticals, Inc.

9EP.F·Frankfurt·Healthcare
Compare
9.15−0.25 (−2.66%)today
As of Nov 5, 8:10 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close9.40
Open9.15
Day range—
52-week range8.6514.20
Off day high0.00%
Off 52-week high−35.56%
Volume2.00
Avg. volume (3M)0.00
Market cap266.50M
EPS (TTM)-2.07
Forward P/E-1.67
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.76
Shares outstanding29.13M
Short interest—
Earnings dateNov 16, 2026 (est.)
Analyst target—
Profit margin−96.89%

Against its peers

Compare in full ›
9EP.F ASMB AVIR EDSA TRDA IVVD
Market cap 266.50M 404.57M 357.71M 29.32M 197.02M 186.76M
P/E (TTM) — 19.1 — — — —
Forward P/E -1.7 -7.7 -3.0 — -1.6 -1.2
Price/book 3.0 1.3 1.8 52.9 0.8 1.0
Dividend yield — — — — — —
1-year change +2.73% −36.33% +37.23% +27.65% −31.99% −61.71%
Today −2.66% −0.25% +6.95% −4.82% +7.20% +8.96%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All 9EP.F news ›

From the 4Search news index, newest first.

In the news

3mentions in 30 days
3with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance